等待開盤 07-18 09:30:00 美东时间
0.000
0.00%
SI-BONE, a medical device company focused on sacropelvic disorders, will report its second quarter 2025 financial results on August 4, 2025, after market close. Management will host a conference call at 4:30 p.m. ET, available for investors via registration. SI-BONE, a global leader in minimally invasive SI joint fusion, has supported over 125,000 procedures since launching its iFuse system in 2009, with over 175 peer-reviewed publications suppor...
07-14 20:09
Bone Biologics filed a USPTO patent for NELL-1 and announced a $5 million offering to support trials and expand its bone regeneration patent portfolio.
06-27 22:23
Bone Biologics shares are trading higher after the compnay announced it filed a...
06-27 20:16
NKE: 11% | Nike Q4 Earnings: Revenue Beat, EPS Beat, Headwinds Expected To Moderate Moving Forward, Company Playing 'Sport Offense' BBLG: 188% | Bone Biologics Files USPTO Patent For rhNELL-1 Protein In
06-27 19:22
Gainers Plus Therapeutics (NASDAQ:PSTV) stock increased by 66.2% to $0.31 duri...
06-26 01:06
Bone Biologics (NASDAQ:BBLG) has filed to offer up to $35M in securities through a shelf registration. The offering may include common stock, preferred stock, warrants, rights, or units in various com...
06-25 05:19
Bone Biologics (NASDAQ:BBLG) on Friday announced a planned reverse stock split of its shares of common stock at a ratio of 1-for-6. The reverse stock split will take effect as of 12:01 a.m. ET, on Tue...
06-06 20:39
SI-BONE, Inc. announced it will participate in the 2025 Goldman Sachs 46th Global Healthcare Conference on June 10, 2025, in Miami Beach, FL. Management will host a fireside chat at 8:20 a.m. PT/11:20 a.m. ET. Investors can access the live audio webcast through the provided links. SI-BONE, a global leader in sacropelvic disorder treatments, has supported over 120,000 procedures since 2009 with its iFuse Implant System.
05-28 20:30